Psych MEQs / SAQs · Old age psychiatry — mood disorders
Late-life bipolar disorder — assessment and management (MEQ)
FRANZCP-style MEQ on late-life bipolar: EOBD continuation, lithium toxicity risk with NSAID/thiazide, GERI-BD-informed mania treatment, suicide lethality/means, ISBD lithium monitoring. FRANZCP-primary, globally tagged.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Formulation and differential. This is early-onset bipolar I disorder continuing into late life with a current manic episode (first illness at 28, not late-onset first mania). Differentials still include lithium toxicity or subtoxicity contributing to confusion/inattention; delirium from medical causes; substance effects; and less likely a new primary secondary mania because of the established bipolar history — but always re-check drugs and medical drivers that can worsen mania.[1][8] Reduced MoCA with inattention may reflect manic distractibility, sleep deprivation, early toxicity, or delirium — clarify with serial attention testing and medical work-up.[1]
(ii) Acute risk and medical priorities. Financial vulnerability and grandiosity with remortgage plans; firearm access; poor sleep; possible impaired capacity. Urgent lithium level and renal function now: ibuprofen (NSAID) plus thiazide plus age/reduced eGFR is a classic toxicity cocktail even if she is not yet floridly toxic.[3][4] Hold NSAID; review thiazide with physician; hydrate as appropriate; ECG, basic labs, consider infection screen. Collateral and capacity assessment for finances/treatment.[6]
(iii) Acute mania management. Hospitalisation threshold is high given risk, sleep collapse, and medical complexity — least-restrictive but safe setting. If lithium level is therapeutic and not toxic, may continue carefully with dose adjustment for eGFR; if toxic or high-normal with symptoms, hold lithium and treat toxicity first.[4] Antimanic options guided by GERI-BD: lithium and divalproex are both efficacious in older mania with careful dosing; add a low-start atypical antipsychotic (e.g. quetiapine 25–50 mg orally, titrate) for behavioural control and sleep if needed.[2][6] Example divalproex start if lithium held: 125–250 mg orally two to three times daily with LFT/platelets/level monitoring. Reassess mania daily; protect sleep; reduce stimulation.[2]
(iv) Suicide/means and disposition. Even with denied ideation, older adults have high suicide lethality — ask fully about depression history, hopelessness, and plans as the pole can switch; secure the firearm same day with family/police pathways as appropriate under local law.[5] Intensity of care: likely inpatient voluntary if capacitous and agreeable, involuntary if risk and incapacity require (jurisdiction-specific). Do not discharge to an empty safety plan with firearm access.[5][6]
(v) Long-term lithium plan. After stabilisation, plan maintenance with age-attuned lithium targets (often roughly 0.4–0.8 mmol/L maintenance, individualised), more frequent level/eGFR/TSH/calcium checks, sick-day rules, interaction list (no OTC NSAIDs), and carer education. BALANCE supports lithium-centred prophylaxis; do not abandon lithium solely for age if benefits outweigh monitored risks.[3][7] Coordinate GP shared care and old-age CMHT follow-up.[6]
Common errors
- Treating this as late-onset first mania without noting the age-28 bipolar history.
- Ignoring NSAID/thiazide/lithium interaction and failing to check an urgent level.
- Omitting firearm means restriction while focusing only on choosing valproate.
- Using young-adult lithium targets of 1.0–1.2 mmol/L as automatic maintenance goals in frailty.
- Inventing Mental Health Act section numbers across jurisdictions. [3][5][6]
Examiner notes
Full marks require EOBD formulation, toxicity interaction recognition, named acute management with geriatric dosing philosophy (GERI-BD), means restriction, and an age-attuned lithium maintenance plan. Vague "admit and give a mood stabiliser" fails. [2][3]
References
- [1]Depp CA, Jeste DV Bipolar disorder in older adults: a critical review Bipolar Disord, 2004.PMID 15383127
- [2]Young RC, Mulsant BH, Sajatovic M, et al. GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder Am J Psychiatry, 2017.PMID 29088928
- [3]Shulman KI, Almeida OP, Herrmann N, et al. Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: An ISBD task force report Bipolar Disord, 2019.PMID 30375703
- [4]McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis Lancet, 2012.PMID 22265699
- [5]Conwell Y, Van Orden K, Caine ED Suicide in older adults Psychiatr Clin North Am, 2011.PMID 21536168
- [6]Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders Aust N Z J Psychiatry, 2021.PMID 33353391
- [7]BALANCE investigators and collaborators, Geddes JR, Goodwin GM, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet, 2010.PMID 20092882
- [8]Krauthammer C, Klerman GL Secondary mania: manic syndromes associated with antecedent physical illness or drugs Arch Gen Psychiatry, 1978.PMID 757997